We are live on
!
Find out more
VYNT
Vyant Bio, Inc. Common Stock
VYNT
VYNT
Delisted
VYNT was delisted on the 12th of May, 2023.
29 hedge funds and large institutions have $2.99M invested in Vyant Bio, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
3% less funds holding
Funds holding: 30 → 29 (-1)
26% less capital invested
Capital invested by funds: $4.04M → $2.99M (-$1.05M)
56% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 9
Holders
29
Holders Change
-1
Holders Change %
-3.33%
% of All Funds
0.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$203K |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$176K |
| 3 |
WS
Wedbush Securities
Los Angeles,
California
|
+$137K |
| 4 |
Squarepoint
New York
|
+$46.8K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$27.7K |
Top Sellers
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$476K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$130K |
| 3 |
EGA
Eagle Global Advisors
Houston,
Texas
|
-$63K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$56.2K |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
-$28K |
